CALP
Caliper Life Sciences IncNASDAQ
CALP is defunct.
  • Sep. 8, 2011, 9:00 AM

    Premarket gainers: CALP +41%. HOV +4%. PAY +3%.
    Losers: DNDN -5%. NBG -4%. ACH -4%. SI -3%. MTG -3%. TS -3%.

    | Sep. 8, 2011, 9:00 AM
  • Sep. 8, 2011, 7:12 AM

    PerkinElmer (PKI) agrees to buy Caliper Life Sciences (CALP) for $10.50 a share, a 42% premium over yesterday's closing price. The $600M deal adds "innovative molecular imaging and detection technologies" to PerkinElmer's portfolio, according to its CEO. Shares of CALP +40% premarket.

    | Sep. 8, 2011, 7:12 AM
  • Feb. 1, 2011, 11:39 AM

    With the 2011 Advances in Genome Biology and Technology conference getting underway tomorrow, life sciences companies may get a little extra attention. Major presenters/participants include Illumina (ILMN), Life Technologies (LIFE), Caliper Life Sciences (CALP), Agilent (A), Pacific Biosciences (PACB), and Complete Genomics (GNOM).

    | Feb. 1, 2011, 11:39 AM